As of June 13, 2025, Callitas Health Inc (LILY.CN) reports a Current Ratio of 0.04.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Callitas Health Inc's Current Ratio
Over recent years, Callitas Health Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2019-12-31 | 0.04 |
| 2018-12-31 | 0.01 |
| 2017-12-31 | 0.04 |
| 2016-12-31 | 0.31 |
| 2015-12-31 | 0.01 |
This slight downward trend highlights how Callitas Health Inc manages its short-term assets and liabilities over time.
Comparing Callitas Health Inc's Current Ratio to Peers
To better understand Callitas Health Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Callitas Health Inc (LILY.CN) | 0.04 |
| Context Therapeutics Inc (CNTX) | 35.62 |
| CTT Pharmaceutical Holdings Inc (CTTH) | 6.19 |
| BiondVax Pharmaceuticals Ltd (BVXV) | 6.15 |
| Synvista Therapeutics Inc (SYNI) | 5.60 |
| Tricida Inc (TCDA) | 4.94 |
Compared to its competitors, Callitas Health Inc's Current Ratio is among the lowest compared to peers, suggesting tighter liquidity management or potential short-term obligations concerns.